These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28073873)

  • 1. Recurrent angioedema associated with pharmacological inhibition of dipeptidyl peptidase IV.
    Hermanrud T; Bygum A; Rasmussen ER
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28073873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?
    Scott SI; Andersen MF; Aagaard L; Buchwald CV; Rasmussen ER
    Curr Diabetes Rev; 2018; 14(4):327-333. PubMed ID: 28201967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.
    Byrd JB; Touzin K; Sile S; Gainer JV; Yu C; Nadeau J; Adam A; Brown NJ
    Hypertension; 2008 Jan; 51(1):141-7. PubMed ID: 18025295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Induced Inhibition of Angiotensin Converting Enzyme and Dipeptidyl Peptidase 4 Results in Nearly Therapy Resistant Bradykinin Induced Angioedema: A Case Report.
    Hahn J; Trainotti S; Hoffmann TK; Greve J
    Am J Case Rep; 2017 May; 18():576-579. PubMed ID: 28539578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug induced angioedema (ACE-inhibitors and other)].
    Fain O; Mekinian A; Gobert D; Khau CA; Javaud N
    Presse Med; 2015 Jan; 44(1):43-7. PubMed ID: 25511647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.
    Grouzmann E; Livio F; Buclin T
    Hypertension; 2009 Sep; 54(3):468-70. PubMed ID: 19581503
    [No Abstract]   [Full Text] [Related]  

  • 7. Bradykinin Metabolism and Drug-Induced Angioedema.
    Smolinska S; Antolín-Amérigo D; Popescu FD
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.
    Brown NJ; Byiers S; Carr D; Maldonado M; Warner BA
    Hypertension; 2009 Sep; 54(3):516-23. PubMed ID: 19581505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists.
    Kyrmizakis DE; Papadakis CE; Liolios AD; Karatzanis AD; Malandrakis S; Skoulakis CE; Bizakis JG; Velegrakis GA
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1416-9. PubMed ID: 15611402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates.
    Millot I; Plancade D; Hosotte M; Landy C; Nadaud J; Ragot C; Graffin B; Drouet C; Kanny G
    Br J Anaesth; 2012 Nov; 109(5):827-9. PubMed ID: 23066003
    [No Abstract]   [Full Text] [Related]  

  • 11. DPP-4 inhibitors and angioedema: a cause for concern?
    Byrd JS; Minor DS; Elsayed R; Marshall GD
    Ann Allergy Asthma Immunol; 2011 May; 106(5):436-8. PubMed ID: 21530877
    [No Abstract]   [Full Text] [Related]  

  • 12. Iatrogenic angioedema associated with ACEi, sitagliptin, and deficiency of 3 enzymes catabolizing bradykinin.
    Beaudouin E; Defendi F; Picaud J; Drouet C; Ponard D; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2014 May; 46(3):119-22. PubMed ID: 24853572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced, life-threatening angioedema revisited.
    Thompson T; Frable MA
    Laryngoscope; 1993 Jan; 103(1 Pt 1):10-2. PubMed ID: 8380620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?
    Grouzmann E; Buclin T
    Hypertension; 2008 Jan; 51(1):45-7. PubMed ID: 18025291
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema].
    Nosbaum A; Bouillet L; Floccard B; Javaud N; Launay D; Boccon-Gibod I; Fain O; ;
    Rev Med Interne; 2013 Apr; 34(4):209-13. PubMed ID: 23380506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ACE-inhibitor-induced angioedema. The most frequent cause of oropharyngeal edema].
    Leuwer A; Krause J
    HNO; 1998 Jan; 46(1):56-9. PubMed ID: 9539057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
    Bartal C; Zeldetz V; Stavi V; Barski L
    Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema.
    Lefebvre J; Murphey LJ; Hartert TV; Jiao Shan R; Simmons WH; Brown NJ
    Hypertension; 2002 Feb; 39(2 Pt 2):460-4. PubMed ID: 11882590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema.
    Stone C; Brown NJ
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):483-495. PubMed ID: 28687104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPP-IV Inhibitor-Associated Angioedema in Patient With Known History of ACE Inhibitor Angioedema.
    Ejikeme C; Nwachukwu C; Viechweg JL; Ejikeme I; Brescia M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211033049. PubMed ID: 34330175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.